SAKK at the European Society for Medical Oncology (ESMO) Congress

The following SAKK trials are being presented at this year’s ESMO Congress to be held in Barcelona from September 27 to October 1, 2019:

SAKK at the European Society for Medical Oncology (ESMO) Congress

The following SAKK trials are being presented at this year’s ESMO Congress to be held in Barcelona from September 27 to October 1, 2019:
  • Metaxas I. et al. SAKK 17/16: Lurbinectedin as second or third line palliative chemotherapy in malignant pleural mesothelioma (MPM): A multi-center, single-arm Phase II trial.

Metaxas

Session name: Proffered Paper session
Date: 30.09.2019
Lecture Time: 11:06 - 11:18
Location: Pamplona Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain

Please find more information on the ESMO website.

ESMO oral presentation SAKK 17/16

 

  • Digklia A. et al. SAKK 57/16: NAPAGE: NAb-PAclitaxel and GEmcitabine in advanced soft tissue sarcoma. A multicenter open-label single arm phase Ib/IIa trial

Digklia

Session name: Poster Display Session
Date: 28.09.2019
Lecture Time: 12:20
Location: Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain

Please find more information on the ESMO website.

ESMO poster SAKK 57/16

 

  • Mark M. et al. SAKK 95/16: Patterns of care for patients with metastatic bone disease in solid tumors – a cross sectional survey study

Mark

Session name: Poster Display session
Date: 28.09.2019
Lecture Time: 12:20
Location: Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain

Please find more information on the ESMO website. 

ESMO poster SAKK 95/16

All News
11 October 2019